Evidence map›Paper›PMID 6818074›Full record

ArticleDiabetes1982

Acetone metabolism during diabetic ketoacidosis.

O E Owen, V E Trapp, C L Skutches, M A Mozzoli, R D Hoeldtke, G Boden, G A Reichard

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes, 1982. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05541484 (Ketone Monitoring in T1D), which is not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05541484 phase4completedstarted 2022, after this paper: background citation

Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency

Ran2022Enrolled21Registered outcomes3Posted comparisons1ConditionsDiabetes Mellitus, Type 1ArmsBiosense Breath Ketone Analyzer, SGLT2 inhibitor
Open the trial in the graph
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 180 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

O E Owen
V E Trapp
C L Skutches
M A Mozzoli
R D Hoeldtke
G Boden
G A Reichard
Temple University · USLankenau Medical Center · US

Funding

SOMATOSTATIN: NEURAL CONTROL OF RELEASE &METABOLISMR01AM019397 · AM · TEMPLE UNIVERSITY · PI BODEN, GUENTHER · 1985 to 1985
–
NIADDK NIH HHS AM13527NIADDK NIH HHS AM19397NIADDK NIH HHS AM25386
6 · The paper itself

Abstract

The presence and the importance of acetone and its metabolism in diabetic ketoacidosis has largely been ignored. Therefore, we studied acetone metabolism in nine diabetic patients in moderate to severe ketoacidosis. The concentration of acetone in plasma, urine, and breath, and the rates of acetone production and elimination in breath and urine were determined and the rates of vivo metabolism were calculated. Plasma acetone concentrations (1.55-8.91 mM) were directly related and were generally greater than acetoacetate concentrations (1.16-6.08 mM). The rates of acetone production ranged from 68 to 581 mumol/min/1.73 m2, indicating the heterogeneous nature of the patients studied. The average acetone production rate was 265 mumol/min/1.73 m2 and accounted for about 52% of the estimated acetoacetate production rate. Urinary excretion of acetone remained constant and accounted for about 7% of the acetone production rate in all patients. There was a positive linear relationship between the percentage of the acetone production rate accounted for by excretion in breath and the plasma acetone concentration. At low plasma acetone concentrations, approximately 20%, and at high plasma acetone concentrations, approximately 80% of the production rate was accounted for by breath acetone. In contrast, there was a negative linear relationship between the percentage of acetone production rate undergoing in vivo metabolism and plasma acetone concentration. At low plasma acetone concentrations, approximately 75%, and at high concentrations, approximately 20% of acetone production rate was accounted for by in vivo metabolism. Radioactivity from 2-[14C]-acetone was variably present in plasma acetone, glucose, lipids and proteins. No radioactivity was found in plasma acetoacetate, beta-hydroxy butyrate or free fatty acids or other anionic compounds. Exchange rates of acetone into other metabolites could not be estimated because of non-steady-state precursor product relationships in these patients.

Indexed as

AcetoneAdultAgedBiotransformationBlood GlucoseBreath TestsDiabetic KetoacidosisFemaleHumansKetone BodiesMaleMiddle AgedAcetoneBlood GlucoseKetone Bodies

Identifiers

PMID6818074
OpenAlexW2102289822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.